TuHURA BIOSCIENCES, INC./NV Other Comprehensive Income (Loss), Net of Tax
TuHURA BIOSCIENCES, INC./NV (HURA) reported Other Comprehensive Income (Loss), Net of Tax of $2.67 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2017-11-09
- TuHURA BIOSCIENCES, INC./NV other comprehensive income (loss), net of tax for the quarter ending 2017-09-30 was $2.67M, a 16.42% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV other comprehensive income (loss), net of tax for the quarter ending 2016-09-30 was $2.29M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 0 month | Other Comprehensive Income (Loss), Net of Tax 3 month |
|---|---|---|
| 2017-09-30 | $2.67M 10-Q · filed 2017-11-09 | |
| 2016-09-30 | $2.29M 10-Q · filed 2017-11-09 | |
| 2012-06-30 | -$18.89K 10-K/A · filed 2012-12-20 | |
| 2011-06-30 | -$33.21K 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |